The Centers for Disease Control is holding an emergency meeting to review the Johnson & Johnson COVID-19 vaccine.
Both the FCD and CDC have recommended pausing its use following six reports of a rare and severe blood clot.
The Centers for Disease Control is holding an emergency meeting to review the Johnson & Johnson COVID-19 vaccine.
Both the FCD and CDC have recommended pausing its use following six reports of a rare and severe blood clot.
CDC vaccine advisers are meeting today to review six “rare and severe” blood clot cases among more than 6.8 million Americans..